Ionizing radiation exposure after allogeneic hematopoietic cell transplantation

Christina Cho; Molly A. Maloy; Sean M. Devlin; Omer Aras; Lawrence T. Dauer; Ann A. Jakubowski; Esperanza B. Papadopoulos; Miguel Angel Perales; Theodore S. Rappaport; Sergio A. Giralt

doi:10.1038/s41409-022-01612-x

Ionizing radiation exposure after allogeneic hematopoietic cell transplantation

Christina Cho, Molly A. Maloy, Sean M. Devlin, Omer Aras, Lawrence T. Dauer, Ann A. Jakubowski, Esperanza B. Papadopoulos, Miguel Angel Perales, Theodore S. Rappaport, Sergio A. Giralt

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	827-829
Number of pages	3
Journal	Bone Marrow Transplantation
Volume	57
Issue number	5
DOIs	https://doi.org/10.1038/s41409-022-01612-x
State	Published - May 2022

ASJC Scopus subject areas

Hematology
Transplantation

Access to Document

10.1038/s41409-022-01612-x

Cite this

@article{a65684bd135147e7b87d7936d2fb250c,

title = "Ionizing radiation exposure after allogeneic hematopoietic cell transplantation",

author = "Christina Cho and Maloy, {Molly A.} and Devlin, {Sean M.} and Omer Aras and Dauer, {Lawrence T.} and Jakubowski, {Ann A.} and Papadopoulos, {Esperanza B.} and Perales, {Miguel Angel} and Rappaport, {Theodore S.} and Giralt, {Sergio A.}",

note = "Funding Information: This work was supported by the NYU WIRELESS industrial affiliates program and in part by National Institutes of Health award number P01 CA23766 and NIH/NCI Cancer Center Support Grant P30 CA008748. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funding Information: CC, MAM, SMD, OA, LTD, AAJ, EBP, and TSR: none. MAP: Reports honoraria from Abbvie, Astellas, Celgene, Bristol-Myers Squibb, Incyte, Karyopharm, Kite/Gilead, Merck, Miltenyi Biotec, MorphoSys, Novartis, Nektar Therapeutics, Omeros, and Takeda. He serves on DSMBs for Cidara Therapeutics, Servier and Medigene and the scientific advisory board of NexImmune. He has received research support for clinical trials from Incyte, Kite/Gilead, Miltenyi Biotec, and Novartis. He serves in a volunteer capacity as a member of the Board of Directors of Be The Match (National Marrow Donor Program, NMDP), as well as on the CIBMTR Cellular Immunotherapy Data Resource (CIDR) Executive Committee. SAG: Reports honoraria and consulting fees from Actinium, Amgen, Celgene, Jazz Scientific, Kite, Novartis, Omeros, and Miltenyi; and research funding from Actinium, Amgen, BMS, Celgene, Janssen, Novartis, Miltenyi, Pfizer, Sanofi, and Takeda. He has served on scientific advisory boards for Actinium, BMS, Celgene, GSK, Jazz Scientific, Janssen, Pfizer, and Sanofi. ",

year = "2022",

month = may,

doi = "10.1038/s41409-022-01612-x",

language = "English (US)",

volume = "57",

pages = "827--829",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

number = "5",

}

TY - JOUR

T1 - Ionizing radiation exposure after allogeneic hematopoietic cell transplantation

AU - Cho, Christina

AU - Maloy, Molly A.

AU - Devlin, Sean M.

AU - Aras, Omer

AU - Dauer, Lawrence T.

AU - Jakubowski, Ann A.

AU - Papadopoulos, Esperanza B.

AU - Perales, Miguel Angel

AU - Rappaport, Theodore S.

AU - Giralt, Sergio A.

N1 - Funding Information: This work was supported by the NYU WIRELESS industrial affiliates program and in part by National Institutes of Health award number P01 CA23766 and NIH/NCI Cancer Center Support Grant P30 CA008748. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funding Information: CC, MAM, SMD, OA, LTD, AAJ, EBP, and TSR: none. MAP: Reports honoraria from Abbvie, Astellas, Celgene, Bristol-Myers Squibb, Incyte, Karyopharm, Kite/Gilead, Merck, Miltenyi Biotec, MorphoSys, Novartis, Nektar Therapeutics, Omeros, and Takeda. He serves on DSMBs for Cidara Therapeutics, Servier and Medigene and the scientific advisory board of NexImmune. He has received research support for clinical trials from Incyte, Kite/Gilead, Miltenyi Biotec, and Novartis. He serves in a volunteer capacity as a member of the Board of Directors of Be The Match (National Marrow Donor Program, NMDP), as well as on the CIBMTR Cellular Immunotherapy Data Resource (CIDR) Executive Committee. SAG: Reports honoraria and consulting fees from Actinium, Amgen, Celgene, Jazz Scientific, Kite, Novartis, Omeros, and Miltenyi; and research funding from Actinium, Amgen, BMS, Celgene, Janssen, Novartis, Miltenyi, Pfizer, Sanofi, and Takeda. He has served on scientific advisory boards for Actinium, BMS, Celgene, GSK, Jazz Scientific, Janssen, Pfizer, and Sanofi.

PY - 2022/5

Y1 - 2022/5

UR - http://www.scopus.com/inward/record.url?scp=85124810346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124810346&partnerID=8YFLogxK

U2 - 10.1038/s41409-022-01612-x

DO - 10.1038/s41409-022-01612-x

M3 - Letter

C2 - 35184148

AN - SCOPUS:85124810346

SN - 0268-3369

VL - 57

SP - 827

EP - 829

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 5

ER -

Ionizing radiation exposure after allogeneic hematopoietic cell transplantation

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this